Implementation support for contingency management: preferences of opioid treatment program leaders and staff.
Contingency management
Implementation support
Opioid use disorder
Journal
Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360
Informations de publication
Date de publication:
30 Apr 2021
30 Apr 2021
Historique:
received:
18
09
2020
accepted:
20
04
2021
entrez:
1
5
2021
pubmed:
2
5
2021
medline:
2
5
2021
Statut:
epublish
Résumé
Contingency management (CM), a behavioral intervention that provides incentives for achieving treatment goals, is an evidence-based adjunct to medication to treat opioid use disorder. Unfortunately, many front-line treatment providers do not utilize CM, likely due to contextual barriers that limit effective training and ongoing support for evidence-based practices. This study applied user-informed approaches to adapt a multi-level implementation strategy called the Science to Service Laboratory (SSL) to support CM implementation. Leaders and treatment providers working in community-based opioid treatment programs (OTPs; N = 43) completed qualitative interviews inquiring about their preferences for training and support implementation strategies (didactic training, performance feedback, and external facilitation). Our team coded interviews using a reflexive team approach to identify common a priori and emergent themes. Leaders and providers expressed a preference for brief training that included case examples and research data, along with experiential learning strategies. They reported a desire for performance feedback from internal supervisors, patients, and clinical experts. Providers and leaders had mixed feelings about audio-recording sessions but were open to the use of rating sheets to evaluate CM performance. Finally, participants desired both on-call and regularly scheduled external facilitation to support their continued use of CM. This study provides an exemplar of a user-informed approach to adapt the SSL implementation support strategies for CM scale-up in community OTPs. Study findings highlight the need for user-informed approaches to training, performance feedback, and facilitation to support sustained CM use in this setting.
Sections du résumé
BACKGROUND
BACKGROUND
Contingency management (CM), a behavioral intervention that provides incentives for achieving treatment goals, is an evidence-based adjunct to medication to treat opioid use disorder. Unfortunately, many front-line treatment providers do not utilize CM, likely due to contextual barriers that limit effective training and ongoing support for evidence-based practices. This study applied user-informed approaches to adapt a multi-level implementation strategy called the Science to Service Laboratory (SSL) to support CM implementation.
METHODS
METHODS
Leaders and treatment providers working in community-based opioid treatment programs (OTPs; N = 43) completed qualitative interviews inquiring about their preferences for training and support implementation strategies (didactic training, performance feedback, and external facilitation). Our team coded interviews using a reflexive team approach to identify common a priori and emergent themes.
RESULTS
RESULTS
Leaders and providers expressed a preference for brief training that included case examples and research data, along with experiential learning strategies. They reported a desire for performance feedback from internal supervisors, patients, and clinical experts. Providers and leaders had mixed feelings about audio-recording sessions but were open to the use of rating sheets to evaluate CM performance. Finally, participants desired both on-call and regularly scheduled external facilitation to support their continued use of CM.
CONCLUSIONS
CONCLUSIONS
This study provides an exemplar of a user-informed approach to adapt the SSL implementation support strategies for CM scale-up in community OTPs. Study findings highlight the need for user-informed approaches to training, performance feedback, and facilitation to support sustained CM use in this setting.
Identifiants
pubmed: 33931126
doi: 10.1186/s43058-021-00149-2
pii: 10.1186/s43058-021-00149-2
pmc: PMC8088083
doi:
Types de publication
Journal Article
Langues
eng
Pagination
47Subventions
Organisme : NIDA NIH HHS
ID : R01DA046941
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20GM125507
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM125507
Pays : United States
Organisme : NIDA NIH HHS
ID : K23 DA050729
Pays : United States
Organisme : NIAAA NIH HHS
ID : T32AA007459
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA046941
Pays : United States
Références
J Soc Serv Res. 2011 Jul 1;37(4):390-402
pubmed: 21927521
BMC Health Serv Res. 2019 Jul 9;19(1):466
pubmed: 31288797
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Implement Sci. 2018 Feb 22;13(1):35
pubmed: 29471849
Addiction. 2011 Feb;106(2):428-41
pubmed: 20925684
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Prof Psychol Res Pr. 2020 Apr;51(2):134-144
pubmed: 32982034
Arch Gen Psychiatry. 2002 Sep;59(9):817-24
pubmed: 12215081
Drug Alcohol Depend. 2012 Mar 1;121(3):205-12
pubmed: 21925807
Subst Abus. 2018;39(2):211-217
pubmed: 29522381
J Psychoactive Drugs. 2013 Jan-Mar;45(1):17-27
pubmed: 23662328
Drug Alcohol Depend. 2010 Jun 1;109(1-3):167-74
pubmed: 20149950
JMIR Res Protoc. 2019 Oct 9;8(10):e14990
pubmed: 31599736
Drug Alcohol Depend. 2000 Feb 1;58(1-2):55-66
pubmed: 10669055
Cogn Behav Pract. 2014 Feb;21(1):1-11
pubmed: 25382963
J Subst Abuse Treat. 2014 Apr;46(4):429-38
pubmed: 24462242
Adm Policy Ment Health. 2011 Jul;38(4):238-53
pubmed: 21190075
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75
pubmed: 25747920
Subst Abus. 2011 Oct;32(4):180-90
pubmed: 22014248
Implement Sci. 2017 Sep 29;12(1):117
pubmed: 28962632
Drug Alcohol Depend. 2007 Mar 16;87(2-3):107-18
pubmed: 17023123
J Subst Abuse Treat. 2002 Sep;23(2):81-6
pubmed: 12220605
J Consult Clin Psychol. 2005 Feb;73(1):106-15
pubmed: 15709837
BMC Psychol. 2015 Sep 16;3:32
pubmed: 26376626
Clin Psychol (New York). 2010 Mar;17(1):1-30
pubmed: 20877441
Transl Behav Med. 2019 Nov 25;9(6):1057-1064
pubmed: 30535343
J Public Health Dent. 2011 Winter;71(s1):S52-S63
pubmed: 21499543
Psychiatrist. 2011 May;35(5):161-163
pubmed: 22558006
Clin Psychol (New York). 2016 Jun;23(2):180-200
pubmed: 29456295
Nurse Educ Today. 2004 Feb;24(2):105-12
pubmed: 14769454
J Subst Abuse Treat. 2018 Dec;95:26-34
pubmed: 30352667
J Subst Abuse Treat. 2008 Apr;34(3):293-301
pubmed: 17600652
Int J Nurs Stud. 2010 Nov;47(11):1451-8
pubmed: 20598692
J Subst Abuse Treat. 2000 Sep;19(2):117-26
pubmed: 10963923
J Subst Abuse Treat. 2012 Mar;42(2):134-42
pubmed: 22154040
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
J Behav Health Serv Res. 2017 Apr;44(2):177-194
pubmed: 26289563
J Clin Psychol. 2010 Jan;66(1):73-95
pubmed: 19899142
Subst Abus. 2016;37(1):134-40
pubmed: 26682582